According to the latest report by Renub Research “Proton Therapy Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Global Proton Therapy Market Size was US$ 68.1 Billion in 2021. Proton therapy is an excellent treatment alternative for numerous patients, especially those with tumors close to vital organs. Besides, for children, those most vulnerable and susceptive to the damage of conventional radiation therapy, proton therapy offers less radiation exposure while demoting side effects. In addition, proton therapy is a high-tech option for X-ray radiation. With online image guidance, a scanning beam of proton radiation advises greater precision to destroy carcinogenic cells, sparing adjacent healthy tissue with more infrequent side effects.

Factors Fuelling the Growth of the Global Proton Therapy Market:

The growth of the proton therapy market across the world is mainly driven by rising healthcare expenditure, expanding preference for advanced therapies by healthcare practitioners, increasing confirmation, and increasing cancer pervasiveness. Another outstanding growth driver is the faster uptake and access and premium pricing. Further, the Worldwide Proton Therapy Market is growing at a CAGR of 2.07% during the period 2021-2027.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-proton-therapy-market-and-forecast-12-countries-market-data-patients-treated-at-proton-therapy-centers-reimbursement-policies-1073-p.php

The United States has the Largest Number of Proton Therapy Centres Globally:

The United States is the proton therapy industry's hub, having the highest number of proton therapy hubs globally. The United Kingdom is anticipated to launch advanced multi-room proton therapy centers owned by the NHS and Private Players in the future. Besides, the emerging countries are also escalating their demand for proton therapy in their territories as some cancer and cancer-related cases have been surging and will undoubtedly boost the growth of this market during the forecast period.

Competitive Landscape:

Companies existing in the Global Proton Therapy Market are trying to create their mark by adopting new technologies at an accelerated rate. The company has also tried to enrich its product catalogs through product developments. Also, companies have acquired small companies to resolve the potential resource gap that prevailed in their technologies and products. The major players in the Global Proton Therapy Market studied in our report are IBA Proton Therapy, Varian Medical Systems, and Elekta.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-proton-therapy-market-and-forecast-12-countries-market-data-patients-treated-at-proton-therapy-centers-reimbursement-policies-1073-p.php

COVID-19 Impact on Global Proton Therapy Industry:

Despite the outbreak of COVID-19 worldwide, the proton therapy market has expanded at a constant rate. Proton radiation therapy was discontinued for a brief round period, but it was renewed for patients. In addition, to take care of the regular patient and radiation therapies patients across the world, many processes have been finalized to help the patients with therapies; as such many implementations and algorithms have been carried out to safeguard the radiation patients from COVID-19.

Market Summary:

• Countries: In our report we have covered the proton therapy market of United States, United Kingdom, Switzerland, Russia, Germany, France, Italy, Sweden, Poland, Japan, Korea, China,
• Company: We have covered the key players including IBA Proton Therapy, Varian Medical Systems, Elekta

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research titled, “Lung Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Lung Cancer Screening Market Size was US$ 15.4 Billion in 2021. Lung cancer is the ultimate cause of cancer death among both women and men globally. Thus, lung cancer screening aims to detect lung cancer before it has spread; this can help find cancer early. However, the only recommended screening test for lung cancer is low-dose computed tomography (also called a low-dose C.T. scan, or LDCT), Chest x-ray, and Sputum cytology. Screening with LDCT scans has been conferred to decrease the risk of dying from lung cancer in heavy smokers. Screening by chest x-rays and sputum cytology does not reduce the risk of dying of lung cancer. Furthermore, lung cancer screening is a method used to detect lung cancer in otherwise healthy people with a high risk of lung cancer.

Worldwide Lung Cancer Screening Industry to Grow with a CAGR of 1.4% from 2021 to 2027

According to Statista the increasing incidence of lung cancer death is one of the significant factors driving the lung cancer screening industry. For instance, in 2020, around 1.79 Million cancer deaths, or 18% of all cancer deaths worldwide, were attributed to lung cancer. Further, the increasing number of screening test approvals from regulatory bodies is to drive the growth of the lung cancer screening market. For instance, in 2021, the U.S. Food and Drug Administration (FDA) announced approval for Amgen’s Sotorasib to treat patients with metastatic non-small cell lung cancer (NSCLC) or locally advanced with KRAS G12C mutation.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=lung-cancer-screening-market-p.php

Non-small Cell Lung Cancer (NSCLC) Segment Holds the Lion’s Share

Based on cancer type, the global lung cancer screening market is segmented into non-small cell lung cancer (NSCLC) and small cell lung cancer. For instance, according to the (ACS) American Cancer Society, about 84% of all lung cancers are non-small cell, and 13% are SCLC. The growing awareness about screening in developed and developing countries combined with the ever-increasing cases of NSCLC across the globe demand for screening lung cancer type is done with a test called a spiral computed tomography or low-dose helical (C.T. or CAT) scan.

Healthcare like Hospitals & Clinics, Research institutes, and Diagnostic Centers play an active role in making people aware and educated about lung cancer screening. Doctors used conventional chest X-rays to check for signs of lung cancer, such as a suspicious spot. While traditional X-rays help detect lung cancer, they offer less detailed pictures from one angle than more advanced imaging technology, like C.T. scans, that use X-rays from multiple angles to make clear images of the lungs. Moreover, because of the National Lung Screening Trial and support from leaders in lung cancer treatment and prevention, low-dose C.T. scans of the chest are a standard of care in hospitals across the world.

Lung Cancer Incidence and Mortality in China have been Increasing Rapidly

Geographically, United States holds the most crucial requirement for lung cancer screening due to the rising lung cancer cases, progressing implementation of technologically advanced solutions and robust application of cancer screening courses, which are few of the aspects accountable for the domination of United States. For instance, as per the American Society of Clinical Oncology (2020), lung cancer is the second greatest basic cancer occurring in men and women and was assessed to affect more than 235,000 adults in the U.S.

In Germany, the lung cancer screening industry has grown due to increasing cancer awareness and introducing new medical diagnostic equipment and advanced therapies. The expanding elderly population, changing lifestyles, and rising tobacco smoking, including passive smoking, are likely drivers for the German lung cancer screening market. Likewise, as per the Global Cancer Observatory (Globocan), around 64,804 new cases of lungs cancer were identified in Germany in the year 2020.

COVID-19 Outbreak:

The outbreak of COVID-19 has hindered the lung cancer screening market since its arrival. This pandemic has created a commotion in the supply chain of clinical material. Consequently, there has been a rise in demand for global imaging solutions. Nevertheless, disruption in production and the industrial procedure has led to a disadvantageous impact on the market globally.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/lung-cancer-screening-market-p.php

Robust Portfolio, Strong Distribution Network, and New Product Launch to help Key Players Lead

The global lung cancer screening market is consolidated with key players, including llumina, Inc, Abbott Laboratories, Thermo Fisher Scientific, Inc, QIAGEN N.V. and Roche Holding AG. The dominance of these major companies is attributed to the strong product portfolio of screening devices, robust distribution network, mergers and acquisitions, and introduction of new products in the market.

Market Summary:

• Cancer Type - We have covered Global Lung Cancer Screening Market breakup by 2 viewpoints by Cancer Type (Non-small cell lung cancer (NSCLC) and Small cell lung cancer)
• End User - Renub Research Report has covered by End User in the 4 viewpoints (Hospitals & Clinics, Research institutes and Diagnostic Centers and Others)
• Country – Our Report has covered Lung Cancer Screening Market breakup by 3 countries (United States, Canada, Norway, Italy, France, Germany, United Kingdom, Russia, Spain, China, India, Japan and South Korea)
• All the key players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) llumina Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, QIAGEN N.V. and Roche Holding AG.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research, “4K Medical Imaging Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” the 4K Medical Imaging Market is expected to be USD 1.7 Billion by 2027. Digital medical imaging technology has grown rapidly in the last few decades and is widely used as a medical diagnostic tool. The medical enterprise is in the throes of entering a unique epoch in imaging technology. Healthcare specialists are upgrading to ultra-high-definition 4K resolution as innovative technology delivers four times more clarity than high definition. 4K imaging is a display panel that delivers high-definition video.The 4K technology has changed the perspective of the healthcare sector. The technology allows access of images that will ultimately help in providing efficient treatment.

Further, imagine seeing tissue, blood vessels, and organs in detail in richer detail than full HD. The sharper 4K picture provides a more real-to-life clarity of color and detail, making microsurgical crucial in minimally invasive and general surgery procedures. Now everyone in the OR (operating room) can have a better realistic view of the procedure. Video and still images caught and displayed in 4K give surgeons and clinical staff enhanced perception of fine details during complex procedures with virtually no pixilation.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=4k-medical-imaging-market-p.php

Factors Influencing the 4K Medical Imaging Industries

• The increasing need for hybrid operational rooms is the primary factor that will benefit the global 4K medical imaging industry.
• Rising healthcare expenditure is forecast to offer ample opportunities for companies flourishing in the global .
• The 4K medical imaging market is witnessing increasing demand for visualization quality for medical imaging. Furthermore, growing cases of chronic diseases increase the demand for technologically advanced products.
• The rising demand for flexible designs of 4K medical imaging technology will propel the market growth during the forecast period.

COVID-19 Impact on 4K Medical Imaging Growth Rate

The COVID-19 pandemic has resulted in economic disruption for various countries. This worldwide pandemic has suddenly burdened the healthcare bodies and caused the governments to focus on the COVID-19 related healthcare infrastructure. Due to this the demand for 4K imaging technologies has decreased for a short period of time. Disruptions in the supply chain also reduced market development. Due to labor unavailability and raw materials, various manufacturing companies had to halt the activities. Therefore, it impacted the global 4K medical imaging industry.

Worldwide 4K Medical Imaging Market Size was USD 855.8 Million in 2021

Based on type, the 4K medical imaging market is segmented into 4K camera systems, 4K medical displays, and 4K Advanced Visualization Systems (Microscopic Systems). The 4K medical displays are growing immensely in the 4K medical imaging industry due to the fast adoption of hybrid operating rooms. It provides various advantages such as integrating different facilities, time, and cost-effectiveness. Similarly, the patients’ data of other devices are displayed on the desired display and offers better visualization quality, further propelling the blossoming of the 4K medical imaging market. Likewise, the 4K medical display market includes medical displays 4K UHD (3840*2160) and 4K DCI (4096*2160) medical displays.

North America 4K Medical Imaging Market is Driving the Growth Worldwide

Geographically, North America is the most considerable market for 4K medical imaging, owing to the growing demand for advanced technology in the region healthcare sector. In addition, favorable government initiatives increased healthcare expenditure, and prominent players like STERIS would contribute to the market development. The rising awareness about the benefits and high-resolution properties of 4K medical imaging technology further boosts the devices' demand. Moreover, the increasing geriatric population and the growing prevalence of chronic diseases will benefit the regional market.

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/4k-medical-imaging-market-p.php

Competitive Landscape

The primary players covered in the 4K medical imaging industry are Sony Corporation, B. Braun Melsungen, Stryker Corporation, Smith & Nephew plc, Eizo Corporation, Stryker, Conmed Corporation, Medtronic plc, Siemens Healthineers, Zimmer Biomet Holdings, Inc.

Market Summary:

• Type - We have covered Market breakup by 4 viewpoints by type (4K Display, 4KIP Cameras, 4K Advanced Visualization Systems, and Others (4K Surgical Recorder, 4K Surgical Monitors)
• End User - Our Report covers by End Users in the 3 viewpoints (Hospitals, Diagnostic Centers and Others)
• Region - This Report covers Global 4K Medical Imaging Market breakup by 4 Region ( North America, Europe, Asia- Pacific and Rest of World)
• The key companies have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) Sony Corporation, B. Braun Melsungen, Stryker Corporation, Smith & Nephew plc, Eizo Corporation, Stryker, Conmed Corporation, Medtronic plc, Siemens Healthineers, Zimmer Biomet Holdings, Inc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch